Our development pipeline spans oncology, immunology, neuroscience, and renal disease, advancing from discovery to marketed stages through strategic partnerships with leading global biopharma companies.

We transform differentiated biology into innovative therapies through precision discovery, translational science, and globally connected development.

Our pipeline is built around validated disease mechanisms and serious unmet medical needs. By integrating target discovery, biomarker-driven research, and disciplined clinical development, Oscotec advances programs with the potential to become meaningful medicines for patients worldwide.